Immune cell therapy shows promise for Post-Transplant viral infections
NCT ID NCT04331275
First seen Nov 05, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This study tests whether specially designed immune cells, called viral-specific T-cells, can safely treat viral infections that occur after a solid organ transplant. The cells are made from the patient's own blood and aim to fight viruses like adenovirus, CMV, and EBV. The goal is to reduce the need for strong anti-viral drugs and lower the risk of organ rejection. The trial involves 42 participants and is currently active but not recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIRAL INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.